ArticleOncotarget2018

Survival outcomes of patients with germ cell tumors treated with high-dose chemotherapy for refractory or relapsing disease.

Stefanie Zschäbitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.